Rafferty Asset Management’s Q32 Bio QTTB Stock Holding History
Bought
Maintained
Sold
Other funds holding QTTB
5VM
BG
Rafferty Asset Management's QTTB Position: Q2 2021 in Review
Rafferty Asset Management sold out of Q32 Bio (QTTB) in Q2 2021, closing a stake of 25,422 shares — an estimated $4.31M sold.
Rafferty Asset Management first reported a position in QTTB in Q2 2019 and held it in 6 quarters. The position peaked at $4.31M in Q1 2021. 118 funds tracked by Wall St. Rank hold QTTB as of Q2 2021.
- Rafferty Asset Management reported no remaining Q32 Bio position as of Q2 2021 after selling out during the quarter.
- Rafferty Asset Management sold 25,422 Q32 Bio shares in Q2 2021, an estimated $4.31M.
- Rafferty Asset Management first reported a position in Q32 Bio in Q2 2019 and held it in 6 quarters.
- Rafferty Asset Management's Q32 Bio position peaked at $4.31M in Q1 2021.
- 118 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2021.
Based on Rafferty Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.